GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tellgen Corp (SZSE:300642) » Definitions » 3-Year FCF Growth Rate

Tellgen (SZSE:300642) 3-Year FCF Growth Rate : 12.90% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Tellgen 3-Year FCF Growth Rate?

Tellgen's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥0.08.

During the past 12 months, Tellgen's average Free Cash Flow per Share Growth Rate was 58.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 12 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Tellgen was 18.70% per year. The lowest was -21.70% per year. And the median was 9.75% per year.


Competitive Comparison of Tellgen's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Tellgen's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tellgen's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tellgen's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Tellgen's 3-Year FCF Growth Rate falls into.



Tellgen 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Tellgen  (SZSE:300642) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Tellgen 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Tellgen's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Tellgen (SZSE:300642) Business Description

Traded in Other Exchanges
N/A
Address
No. 115, Lane 572, Bibo Road, Building 1, Zhangjiang Hi-Tech Park, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.
Executives
Zhou Ai Guo Directors, executives
Chen Si Han Securities Affairs Representative

Tellgen (SZSE:300642) Headlines

No Headlines